GTIM Q1 2026 Earnings Modest Profit Amid Challenging Environment FrontView REIT Q1 2026 Earnings EPS Surges Past Estimates with 174 Surprise ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds KALU Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Amid Strong Operational Execution Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses NIXX Q3 2023 Earnings Narrowing Losses Exceed Estimates Shares Decline